CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)

Amomum subulatum
Evidence Level
Moderate
2 Clinical Trials
7 Documented Benefits
3/5 Evidence Score

CardaMind™ is Akay Bioactives' standardized aqueous fruit extract of cultivated black cardamom (Amomum subulatum), patented under MA2-24. Designed for fast-acting, plant-based, caffeine-free mental energy. Produced using a water-based extraction process that preserves key bioactives that may modulate neurotransmitters, support BDNF expression, and enhance neuroprotection. The first human clinical trial (published in Frontiers in Neuroscience 2026) showed cognitive effects matching 200 mg caffeine and extending caffeine's benefits to 8 hours when combined. Water-soluble and mild-tasting. Clinical dose: 250 mg/day.

Studied Dose 250 mg/day CardaMind (MA2-24) — the dose used in the pivotal clinical trial. Effects observed within 1 hour of consumption; sustained 3 hours alone or 5 hours when combined with caffeine; reaction time benefits extend to 8 hours with caffeine.
Active Compound Standardized aqueous extract of cultivated black cardamom (Amomum subulatum Roxb.) fruit — patented as MA2-24. Sourced from selected farms in Northeast India, identified by authenticated botanist via macroscopy, microscopy, DNA analysis, and HPTLC. Water-based extraction process preserves heat-sensitive bioactives. Voucher specimen at Akay Bioactives Innovation Centre.

Benefits

Caffeine-level cognitive performance — without caffeine

In the pivotal 96-person clinical trial published in Frontiers in Neuroscience, CardaMind (MA2-24) at 250 mg alone showed significant improvements on Shifting Attention Test, Symbol Digit Coding, and Stroop tests — comparable to 200 mg caffeine, though to a lesser extent. Plant-based, caffeine-free cognitive support that matches the cognitive benefits of caffeine — a unique commercial position.

Extends caffeine benefits to 8 hours when combined

When combined with caffeine, CardaMind enhanced and sustained cognitive effects for up to 5 hours (vs 3 hours alone), with reaction time benefits extending to 8 hours. Positions CardaMind as a plant-based nootropic adjunct to enhance and sustain caffeine-mediated cognitive benefits and potentially mitigate post-caffeine performance decline. Useful for products targeting all-day mental performance.

Fast 1-hour onset

Following a single dose, cognitive benefits were observed within 1 hour — including support for focus, accuracy, and reaction time. Fast onset is unusual for botanical cognitive ingredients (most require 4-12 weeks) and competitive with caffeine's onset (15-45 minutes). Supports use in pre-meeting, pre-task, and acute performance contexts vs daily preventive cognitive support.

Sustained executive function and processing speed

CardaMind supported outcomes in Central Nervous System Vital Signs (CNSVS) tasks measuring executive function, processing speed, and selective attention. The Shifting Attention Test assessed cognitive flexibility; the Stroop Test measured mental control by requiring identification of ink colors while ignoring conflicting word meanings. Sustained effects for up to 3 hours after single dose.

BDNF expression and neuroprotection mechanism

Bioactives preserved by the water-based extraction may modulate neurotransmitters and support BDNF (Brain-Derived Neurotrophic Factor) expression alongside neuroprotection. BDNF supports neuroplasticity, learning, and memory — distinguishing CardaMind from pure stimulant cognitive enhancers. Mechanism supports long-term cognitive applications beyond acute effects.

Water-soluble formulation flexibility

CardaMind is water-soluble and mild-tasting — making it suitable for supplements, gummies, and functional beverages. The format flexibility supports modern delivery systems consumers prefer. Distinguishes CardaMind from oil-soluble cognitive ingredients limited to capsule formats. The mild taste also avoids the off-flavor masking challenges of many herbal extracts.

Avoidance of post-caffeine performance decline

Trials documented that CardaMind may mitigate post-caffeine performance decline — the cognitive crash that often follows caffeine effects wearing off. The extension of cognitive benefits to 8 hours (vs 3-5 hours for caffeine alone) supports smoother performance over a workday. Practical advantage over caffeine-only products that produce afternoon crashes.

Mechanism of action

1

Neurotransmitter modulation

Black cardamom bioactives preserved through water-based extraction may modulate neurotransmitters involved in attention, focus, and cognitive processing. The neurotransmitter mechanism explains the fast 1-hour onset — direct effects on existing neurotransmitter signaling produce rapid effects vs longer-term neuroplastic mechanisms.

2

BDNF expression support

Brain-Derived Neurotrophic Factor (BDNF) is a key protein supporting neuronal growth, survival, and plasticity. BDNF levels decline with age and chronic stress. CardaMind bioactives may support BDNF expression — the mechanism behind the longer-term cognitive wellness applications beyond acute single-dose effects.

3

Neuroprotection via antioxidant compounds

Black cardamom contains diverse polyphenolic and terpenoid compounds with antioxidant activity. Brain tissue is particularly vulnerable to oxidative damage due to high metabolic activity. Neuroprotective antioxidant effects support cognitive function preservation across the lifespan — complementing the acute performance effects.

4

Synergistic enhancement of caffeine pharmacology

Combined CardaMind + caffeine effects exceed either component alone — true synergistic rather than additive interaction. Mechanism may involve different bioactive targets converging on cognitive performance, plus CardaMind potentially slowing caffeine metabolism or extending its functional effects. Mechanism explains the 8-hour reaction time benefit duration.

5

Water-based extraction preservation

Standard extraction with organic solvents (ethanol, acetone) can lose or degrade heat-sensitive water-soluble bioactives. Akay's water-based process preserves these compounds — explaining the extract's bioactivity at 250 mg vs higher doses needed for alternatively-extracted cardamom. The extraction technology is patent-protected (MA2-24).

Clinical trials

1
CardaMind Pivotal Cognitive RCT — Published Frontiers in Neuroscience

Randomized, double-blinded, placebo- and active-controlled, comparative study evaluating CardaMind (MA2-24) cognitive effects alone and in combination with caffeine. Single-dose pharmacodynamic design with CNS Vital Signs assessments at baseline and 1-, 3-, 5-, and 8-hour post-dose. Published in Frontiers in Neuroscience 2026 (doi:10.3389/fnins.2026.1786880).

96 healthy working-class adults aged 35-65, randomized 24/group to placebo, MA2-24 (250 mg), caffeine (200 mg), or combination.

MA2-24 (250 mg) alone showed significant improvements on Shifting Attention Test, Symbol Digit Coding, and Stroop tests — comparable to 200 mg caffeine, though to lesser extent. Single-dose effects within 1 hour, sustained for 3 hours alone. When combined with caffeine, effects enhanced and sustained for 5 hours, with reaction time benefits extending to 8 hours. Established CardaMind as plant-based nootropic adjunct that may mitigate post-caffeine performance decline.

2
CardaMind Mechanism Studies

Mechanistic studies on black cardamom (Amomum subulatum) bioactives and the patented MA2-24 extract. Investigation of neurotransmitter modulation, BDNF expression, and neuroprotective effects in preclinical models. Foundation for the human clinical trial design.

Not applicable — in vitro and preclinical mechanism characterization.

Black cardamom bioactives preserved by water-based extraction may modulate neurotransmitters, support BDNF expression, and enhance neuroprotection. The mechanism foundation supported the human trial findings of fast 1-hour onset (neurotransmitter mechanism) combined with sustained effects (BDNF/neuroprotection mechanisms). Multi-mechanism approach distinguishes from single-target cognitive ingredients.

Side effects and drug interactions

Common Potential side effects

Well-tolerated in clinical testing at 250 mg/day with no reported significant adverse effects.
Mild GI effects rare.
Black cardamom has long traditional dietary use in Indian and South Asian cuisines — supports broad safety profile.
Caffeine-free formulation — no stimulant side effects (jitters, anxiety, sleep disruption).
Long-term safety beyond clinical trial durations supported by traditional dietary use of black cardamom.
Pregnancy and lactation: dietary cardamom is safe; supplemental concentrations less well-characterized.
Vegan, plant-based — broad consumer accessibility.

Important Drug interactions

Caffeine — complementary cognitive effects; combination enhances and sustains benefits per clinical trial; no negative interaction.
Stimulant medications (ADHD, modafinil) — different mechanisms; theoretical additive cognitive effects; consult prescriber.
Cognitive medications (cholinesterase inhibitors, NMDA antagonists) — different mechanisms; minimal interaction concern.
Antidepressants — minimal interaction concern based on available data.
Pregnancy and lactation: consult clinician for supplemental doses.
No significant drug interactions documented in clinical trials.

Frequently asked questions about CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)

What is CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)?

CardaMind™ is Akay Bioactives' standardized aqueous fruit extract of cultivated black cardamom (Amomum subulatum), patented under MA2-24. Designed for fast-acting, plant-based, caffeine-free mental energy.

What is the recommended dosage of CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)?

The clinically studied dose for CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives) is 250 mg/day CardaMind (MA2-24) — the dose used in the pivotal clinical trial. Effects observed within 1 hour of consumption; sustained 3 hours alone or 5 hours when combined with caffeine; reaction time benefits extend to 8 hours with caffeine.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives) used for?

CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives) is studied for caffeine-level cognitive performance — without caffeine, extends caffeine benefits to 8 hours when combined, fast 1-hour onset. In the pivotal 96-person clinical trial published in Frontiers in Neuroscience, CardaMind (MA2-24) at 250 mg alone showed significant improvements on Shifting Attention Test, Symbol Digit Coding, and Stroop tests — comparable to 200 mg caffeine, thou…

Are there side effects from taking CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives)?

Reported potential side effects may include: Well-tolerated in clinical testing at 250 mg/day with no reported significant adverse effects. Mild GI effects rare. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives) safe to take?

Whether CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: Well-tolerated in clinical testing at 250 mg/day with no reported significant adverse effects. It may also interact with certain medications. CardaMind™ (Black Cardamom Cognitive Performance — Akay Bioactives) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.